Plant Comparison
Boswellia vs Willow Bark
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Boswellia and Willow Bark: they share 6 indicated uses (arthritis / joint pain, back pain, headache, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Boswellia | Willow Bark | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 9/10 | 7/10 | Stronger for Boswellia |
| Back pain | 7/10 | 9/10 | Stronger for Willow Bark |
| Headache | 7/10 | 1/10 | Stronger for Boswellia |
| Inflammation (general) | 5/10 | 8/10 | Stronger for Willow Bark |
| Pain (general) | 9/10 | 9/10 | Comparable evidence |
| Skin irritation | 5/10 | 8/10 | Stronger for Willow Bark |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal anti-inflammatory compounds; AKBA inhibits 5-lipoxygenase. Absorption improves when taken with a high-fat meal.
Additional constituents of the oleo-gum-resin.
Metabolised in the body to salicylic acid - the 'natural aspirin' that gives the analgesic, anti-inflammatory and antipyretic effects.
Pharmacological Actions
Anti-inflammatory (inhibits 5-lipoxygenase / leukotriene synthesis and NF-kB signalling); Reduces inflammatory markers (e.g. hs-CRP) and, in one RCT, improved knee joint-space and reduced osteophytes on radiograph
Boswellic acids, especially acetyl-11-keto-beta-boswellic acid (AKBA) from Boswellia serrata, induce cell-cycle arrest and apoptosis and inhibit proliferation, invasion and metastasis across lung, colorectal and prostate cancers (preclinical, incl. in vivo).
Analgesic and anti-inflammatory for low back pain (moderate evidence; dose-dependent, around 240 mg salicin/day) - in an RCT, 240 mg salicin/day left 39% pain-free vs 6% on placebo within 4 weeks
Analgesic and anti-inflammatory for low back pain (moderate evidence; dose-dependent, around 240 mg salicin/day) - in an RCT, 240 mg salicin/day left 39% pain-free vs 6% on placebo within 4 weeks
Antipyretic (reduces fever)
Traditional & Indicated Uses
Osteoarthritis: reduces joint pain and stiffness and improves function (over at least 4 weeks); Supports inflammatory arthritis including rheumatoid arthritis
Boswellia serrata resin and its triterpenoid AKBA arrest the cell cycle and induce apoptosis in non-small-cell lung cancer, suppress colitis-associated colorectal cancer (NF-kB, gut microbiota) and inhibit prostate cancer (IL-17 pathway) in vitro and in vivo (preclinical).
Supportive in inflammatory bowel disease (ulcerative colitis, Crohn's disease)
inferred from anti-inflammatory action
Analgesic (pain relief); Osteoarthritis: reduces joint pain and stiffness and improves function (over at least 4 weeks)
Relief of joint pain, osteoarthritis and rheumatic complaints
Analgesic and anti-inflammatory for low back pain (moderate evidence; dose-dependent, around 240 mg salicin/day) - in an RCT, 240 mg salicin/day left 39% pain-free vs 6% on placebo within 4 weeks
inferred from anti-inflammatory action
Analgesic and anti-inflammatory for low back pain (moderate evidence; dose-dependent, around 240 mg salicin/day) - in an RCT, 240 mg salicin/day left 39% pain-free vs 6% on placebo within 4 weeks; Relief of joint pain, osteoarthritis and rheumatic complaints
Safety, Cautions & Contraindications
Generally well tolerated; the most commonly reported side effects are mild gastrointestinal symptoms, and allergic reactions are rare.
Boswellic acids can affect drug-metabolising enzymes, so caution is advised when taking other medicines; safety in pregnancy and breastfeeding is not established, so avoid medicinal doses.
Because it works like aspirin, avoid willow bark if you are allergic to aspirin or salicylates, and do NOT give it to children or teenagers with a viral illness (risk of Reye's syndrome). Use caution in asthma (salicylate sensitivity).
Avoid with anticoagulant/antiplatelet medicines (bleeding risk) and in active peptic ulcer; avoid in pregnancy (especially the third trimester) and breastfeeding.
External Ids
Botanical Description
Small to medium deciduous tree with thin, papery, peeling bark. The leaves are pinnately compound with numerous small, toothed leaflets, clustered toward the branch tips. Small, pale yellow to white flowers are borne in axillary racemes. When the bark is cut, it exudes a fragrant, resinous gum (oleo-gum-resin) that hardens into pale, waxy tears - the medicinal part.[12]
Large deciduous tree (Salicaceae), 10-25 m tall (occasionally taller), fast-growing with a broad crown. Leaves are narrow and lance-shaped, silvery-white and silky-hairy beneath, giving the tree a shimmering appearance in the wind. Tiny flowers are borne in catkins appearing with the leaves in spring; the species is dioecious. The fruit is a small capsule releasing cottony-tufted seeds.[12]
Habitat
Native to dry, rocky, hilly terrain of India and parts of the Middle East and North Africa, where it is tapped for its resin much like frankincense (Boswellia sacra).[12]
Native to Europe, western and central Asia and North Africa, growing on damp ground along riverbanks, floodplains and wet meadows; widely planted and naturalised elsewhere.[12]
Harvesting
The bark is deliberately incised and the exuded oleo-gum-resin is allowed to harden and is collected over several days to weeks, then cleaned and graded before use or extraction.[12]
Bark is stripped from young branches (2-3-year-old growth is preferred, as salicin content is highest in younger bark) in spring, when the rising sap makes the bark peel most easily, then dried.[12]
Traditional Uses
Boswellia resin (salai guggul) is a mainstay of Ayurvedic medicine for inflammatory joint and respiratory conditions, and has been burned as incense across many cultures. Modern standardised extracts, rich in boswellic acids, are used for osteoarthritis, inflammatory bowel disease and other inflammatory conditions, directly building on this traditional anti-inflammatory reputation.[12]
Willow bark has one of the longest documented histories of any medicinal plant, used since antiquity (recorded by Hippocrates) as a remedy for pain and fever. Its salicin content, chemically related to aspirin, gives it official European herbal-monograph recognition for mild joint pain, headache and feverish colds, with modern clinical trials supporting benefit for low back pain.[11, 12]
Preparations
Resin extract standardised to boswellic acid (often AKBA) content, taken as capsules or tablets, ideally with a fat-containing meal to aid absorption.
Dosage
Clinical trials in osteoarthritis commonly use extracts providing around 100-250 mg of boswellic acids (or several hundred mg of standardised extract) daily, in divided doses, taken with food. Educational reference only, not a prescription.
Clinical trials for back pain have used around 240 mg salicin/day of standardised extract. Educational reference only, not a prescription; avoid if allergic to aspirin/salicylates, in children/teenagers with a viral illness (Reye's syndrome risk), or alongside anticoagulants.
References
Lookalikes Review
References & Sources
- Siddiqui, M.Z (2011) 'Boswellia serrata, a potential antiinflammatory agent: an overview', Indian Journal of Pharmaceutical Sciences, 73(3), pp. 255-261. doi:10.4103/0250-474X.93507 Meta-analysis / review
https://doi.org/10.4103/0250-474X.93507 - Majeed, M., Majeed, S., Narayanan, N.K. and Nagabhushanam, K (2019) 'A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee', Phytotherapy Research, 33(5), pp. 1457--1468. doi:10.1002/ptr.6338 Randomized trial
https://doi.org/10.1002/ptr.6338 - Karlapudi, V., Sunkara, K.B., Konda, P.R., Sarma, K.V. and Rokkam, M.P (2022) 'Efficacy and Safety of Aflapin, a Novel Boswellia serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study', Journal of the American Nutrition Association, 42(2), pp. 159-168. doi:10.1080/07315724.2021.2014370 Randomized trial
https://doi.org/10.1080/07315724.2021.2014370 - Kirste, S., Treier, M., Wehrle, S.J., Becker, G., Abdel-Tawab, M., Gerbeth, K., Hug, M.J., Lubrich, B., Grosu, A.L. and Momm, F (2011) 'Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial', Cancer, 117(16), pp. 3788-3795. doi:10.1002/cncr.25945 Randomized trial
https://doi.org/10.1002/cncr.25945 - Abdel-Tawab, M., Werz, O. and Schubert-Zsilavecz, M (2011) 'Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data', Clinical Pharmacokinetics, 50(6), pp. 349-369. doi:10.2165/11586800-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11586800-000000000-00000 - Gomaa, A.A., Mohamed, H.S., Abd-Ellatief, R.B. and Gomaa, M.A (2021) 'Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly', Inflammopharmacology, 29(4), pp. 1033-1048. doi:10.1007/s10787-021-00841-8 Meta-analysis / review
https://doi.org/10.1007/s10787-021-00841-8 - Khan, M.A., Ali, R., Parveen, R., Najmi, A.K. and Ahmad, S (2016) 'Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrata', Journal of Ethnopharmacology, 191, pp. 315-323. doi:10.1016/j.jep.2016.06.053 Meta-analysis / review
https://doi.org/10.1016/j.jep.2016.06.053 - Ammon, H.P.T (2010) 'Modulation of the immune system by Boswellia serrata extracts and boswellic acids', Phytomedicine, 17(11), pp. 862-867. doi:10.1016/j.phymed.2010.03.003 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2010.03.003 - Alluri, V.K., Kundimi, S., Sengupta, K., Golakoti, T. and Kilari, E.K (2020) 'An Anti-Inflammatory Composition of Boswellia serrata Resin Extracts Alleviates Pain and Protects Cartilage in Monoiodoacetate-Induced Osteoarthritis in Rats', Evidence-Based Complementary and Alternative Medicine, 2020, pp. 7381625. doi:10.1155/2020/7381625 Preclinical
https://doi.org/10.1155/2020/7381625 - Henrotin, Y., Dierckxsens, Y., Delisse, G., Maes, N. and Albert, A (2022) 'Curcuma and Boswellia serrata extract combination for hand osteoarthritis: an open-label pre-post trial', Pharmaceutical Biology, 60(1), pp. 2295-2299. doi:10.1080/13880209.2022.2147550 Clinical study
https://doi.org/10.1080/13880209.2022.2147550 - Cherepanova, M.O. and Subotyalov, M.A (2023) 'Component Composition and Biological Activity of Oleo-Gum Resin from Boswellia serrata (Burseraceae)', Doklady Biological Sciences, 512(1), pp. 336-342. doi:10.1134/S0012496623700643 Meta-analysis / review
https://doi.org/10.1134/S0012496623700643 - Ammon, H.P.T (2016) 'Boswellic Acids and Their Role in Chronic Inflammatory Diseases', Advances in Experimental Medicine and Biology. doi:10.1007/978-3-319-41334-1_13 Preclinical
https://doi.org/10.1007/978-3-319-41334-1_13 - Yu, G., Xiang, W., Zhang, T., Zeng, L., Yang, K. and Li, J (2020) 'Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis', BMC Complementary Medicine and Therapies. doi:10.1186/s12906-020-02985-6 Meta-analysis / review
https://doi.org/10.1186/s12906-020-02985-6 - Lv, M. and Shao, S. and Zhang, Q. and Zhuang, X. and Qiao, T (2020) 'Acetyl-11-Keto-beta-Boswellic Acid Exerts the Anti-Cancer Effects via Cell Cycle Arrest, Apoptosis Induction and Autophagy Suppression in Non-Small Cell Lung Cancer Cells', OncoTargets and Therapy, 13, pp. 733-744. doi:10.2147/OTT.S236346 Preclinical
https://doi.org/10.2147/OTT.S236346 - Xu, F. and Li, W. and Zheng, X.-J. and Hao, Y. and Yang, Y.-H. and Yang, H. and Zhang, S. and Cao, W.-X. and Li, X.-X. and Zhang, X. and Du, G.-H. and Ji, T.-F. and Wang, J.-H (2025) '3-O-Acetyl-11-Keto-beta-Boswellic Acid Suppresses Colitis-Associated Colorectal Cancer by Inhibiting the NF-kB Signaling Pathway and Remodeling Gut Microbiota', Oncology Research, 33(8), pp. 1969-1989. doi:10.32604/or.2025.062386 Preclinical
https://doi.org/10.32604/or.2025.062386 - Zou, B. and Liu, Q. and Long, Y. and Dai, X. and Tian, X. and Zhou, Q (2025) 'Network Pharmacology Combined with Proteomics Reveals That 3-Acetyl-11-keto-beta-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway', ACS Omega, 10(21), pp. 21813-21822. doi:10.1021/acsomega.5c01683 Preclinical
https://doi.org/10.1021/acsomega.5c01683 - Ragab, E.A. and Abd El-Wahab, M.F. and Doghish, A.S. and Salama, R.M. and Eissa, N. and Darwish, S.F (2023) 'The journey of boswellic acids from synthesis to pharmacological activities', Naunyn-Schmiedeberg's Archives of Pharmacology, 397(3), pp. 1477-1504. doi:10.1007/s00210-023-02725-w Preclinical
https://doi.org/10.1007/s00210-023-02725-w - Liu, X., Machado, G.C., Eyles, J.P., Ravi, V. and Hunter, D.J (2018) 'Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis', British Journal of Sports Medicine, 52(3), pp. 167--175. doi:10.1136/bjsports-2016-097333 Meta-analysis / review
https://doi.org/10.1136/bjsports-2016-097333
- Shara, M. and Stohs, S.J (2015) 'Efficacy and Safety of White Willow Bark (Salix alba) Extracts', Phytotherapy Research, 29(8), pp. 1112-1116. doi:10.1002/ptr.5377 Meta-analysis / review
https://doi.org/10.1002/ptr.5377 - Maistro, E.L., Terrazzas, P.M., Perazzo, F.F., Gaivao, I.O.M. and others (2020) 'Salix alba (white willow) medicinal plant presents genotoxic effects in human cultured leukocytes', Journal of Toxicology and Environmental Health, Part A, 82(23-24), pp. 1223-1234. doi:10.1080/15287394.2019.1711476 Preclinical
https://doi.org/10.1080/15287394.2019.1711476 - Matyjaszczyk, E. and Schumann, R. (EU-FORA) (2018) 'Risk assessment of white willow (Salix alba) in food', EFSA Journal, 16(Suppl 1), pp. e16081. doi:10.2903/j.efsa.2018.e16081 Meta-analysis / review
https://doi.org/10.2903/j.efsa.2018.e16081 - Phillips, H.N., Sharpe, K.T., Endres, M.I. and Heins, B.J (2021) 'Effects of oral white willow bark (Salix alba) and intravenous flunixin meglumine on prostaglandin E2 in healthy dairy calves', JDS Communications, 3(1), pp. 49-54. doi:10.3168/jdsc.2021-0138 Preclinical
https://doi.org/10.3168/jdsc.2021-0138 - Kong, C.S., Kim, K.H., Choi, J.S., Kim, J.E. and others (2014) 'Salicin, an extract from white willow bark, inhibits angiogenesis by blocking the ROS-ERK pathways', Phytotherapy Research, 28(8), pp. 1246-1251. doi:10.1002/ptr.5126 Preclinical
https://doi.org/10.1002/ptr.5126 - Noleto-Dias, C., Ward, J.L., Bellisai, A., Lomax, C. and Beale, M.H (2018) 'Salicin-7-sulfate: A new salicinoid from willow and implications for herbal medicine', Fitoterapia, 127, pp. 166-172. doi:10.1016/j.fitote.2018.02.009 Preclinical
https://doi.org/10.1016/j.fitote.2018.02.009 - Wolfle, U., Haarhaus, B., Kersten, A., Fiebich, B. and others (2015) 'Salicin from Willow Bark can Modulate Neurite Outgrowth in Human Neuroblastoma SH-SY5Y Cells', Phytotherapy Research, 29(10), pp. 1494-1500. doi:10.1002/ptr.5400 Preclinical
https://doi.org/10.1002/ptr.5400 - Gagnier, J.J., van Tulder, M., Berman, B. and Bombardier, C (2006) 'Herbal medicine for low back pain (Cochrane review)', Cochrane Database of Systematic Reviews, (2), pp. CD004504. doi:10.1002/14651858.CD004504.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD004504.pub3 - Oltean, H., Robbins, C., van Tulder, M.W., Berman, B.M. and others (2014) 'Herbal medicine for low-back pain (Cochrane review update)', Cochrane Database of Systematic Reviews, 2014(12), pp. CD004504. doi:10.1002/14651858.CD004504.pub4 Meta-analysis / review
https://doi.org/10.1002/14651858.CD004504.pub4 - Amel Zabihi, N., Mahmoudabady, M., Soukhtanloo, M., Hayatdavoudi, P. and others (2018) 'Salix alba attenuated oxidative stress in the heart and kidney of hypercholesterolemic rabbits', Avicenna Journal of Phytomedicine, 8(1), pp. 63-72. Preclinical
https://scholar.google.com/scholar?q=Salix%20alba%20attenuated%20oxidative%20stress%20in%20the%20heart%20and%20kidney%20of%20hypercholesterolemic%20rabbits - Vlachojannis, J.E., Cameron, M. and Chrubasik, S (2009) 'A systematic review on the effectiveness of willow bark for musculoskeletal pain', Phytotherapy Research. doi:10.1002/ptr.2747 Meta-analysis / review
https://doi.org/10.1002/ptr.2747 - European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Salix [various species], cortex (Salicis cortex)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/salicis-cortex Traditional / reference
https://www.ema.europa.eu/en/medicines/herbal/salicis-cortex - Chrubasik, S., Eisenberg, E., Balan, E., Weinberger, T., Luzzati, R. and Conradt, C (2000) 'Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study', The American Journal of Medicine, 109(1), pp. 9--14. doi:10.1016/S0002-9343(00)00442-3 Randomized trial
https://doi.org/10.1016/S0002-9343(00)00442-3
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.